Oncology and Hematology

4960

LikeLikedUnlike

Episodes 196-210 of 242

Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
MinuteCE®
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
- Kathleen Moore, MD, MS, FASCO
  Peer
1.00 program credits
Testing for Solid Tumors: Tissue and Liquid Biopsy Approaches Using NGS Technologies for cfDNA and ctDNA Analysis
MinuteCE®
Testing for Solid Tumors: Tissue and Liquid Biopsy Approaches Using NGS Technologies for cfDNA and ctDNA Analysis
- Kathleen Moore, MD, MS, FASCO
  Peer
1.00 program credits
Ovarian Cancer: Advances in HER2-Targeted ADCs
MinuteCE®
Ovarian Cancer: Advances in HER2-Targeted ADCs
- Kathleen Moore, MD, MS, FASCO
  Peer
1.00 program credits
MinuteCE®
Targeting HER2 Across Advanced Solid Tumors
- Susana Banerjee, MBBS, MA, FRCP, PhD
  Peer
- Brad McGregor, MD
  Peer
- Kathleen Moore, MD, MS, FASCO
  Peer
- Shubham Pant, MD, MBBS
  Peer
1.00 credits 10 episodes
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
MinuteCE®
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
- Kathleen Moore, MD, MS, FASCO
  Peer
- Brad McGregor, MD
  Peer
1.00 program credits
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
MinuteCE®
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
- Kathleen Moore, MD, MS, FASCO
  Peer
1.00 program credits
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
MinuteCE®
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
- Shubham Pant, MD, MBBS
  Peer
1.00 program credits
Accelerating Evidence-Based Care in LA SCCHN
CME/CE
Accelerating Evidence-Based Care in LA SCCHN
- Ezra Cohen, MD, FRCPSC, FASCO
  Peer
- Sue S. Yom, MD, PhD
  Peer
0.25 credits
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
CME/CE
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
- Jonathan D. Schoenfeld, MD, MPhil, MPH
  Peer
- Robert L. Ferris, MD, PhD
  Peer
0.25 credits
Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC
CME/CE
Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC
- Heather Wakelee, MD, FASCO
  Peer
- Lyudmila Bazhenova, MD
  Peer
0.25 credits
MinuteCE®
RWE Where RCTs Fall Short: Optimizing Frontline Treatment of HR+/HER2- Metastatic Breast Cancer
- Adam Brufsky, MD, PhD
  Peer
- Christopher M. Gallagher, MD
  Peer
0.75 credits 7 episodes
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
MinuteCE®
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
- Christopher M. Gallagher, MD
  Peer
0.75 program credits
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
MinuteCE®
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
- Adam Brufsky, MD, PhD
  Peer
0.75 program credits
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
MinuteCE®
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
- Christopher M. Gallagher, MD
  Peer
0.75 program credits
Unlocking Insights for Underrepresented Patients: The Role of Real-World Evidence in Addressing Limitations of CDK4/6 Inhibitor RCTs
MinuteCE®
Unlocking Insights for Underrepresented Patients: The Role of Real-World Evidence in Addressing Limitations of CDK4/6 Inhibitor RCTs
- Adam Brufsky, MD, PhD
  Peer
0.75 program credits

Oncology and Hematology

Episodes 196-210 of 242

Program Chapters

Segment Chapters

Playlist:

Recommended

Episodes 196-210 of 242

Title

Share on ReachMD

Program Chapters

Segment Chapters

Playlist:

Recommended

Get a Dose of ReachMD in Your Inbox and Practice Smarter Medicine